Video Shorts

AI in Pharma: Bias, Risk Debt, and Digital Twins

Why Real-Time Monitoring Beats Traditional Testing

Making Gen AI Work in Pharma

New FDA Rule Changes Biosimilar Development

How Counterfeiters Are Fooling The System

Improving FDA Submissions with Better Clinical Models

USP’s Strategy for Supply Chain Resilience

The Power of Seeing Your Molecule in Real-Time

Stop Biasing Your Clinical Data With Simple Models

Two-Minute Mysteries: How Nanexa Achieves Favorable Regulatory Pathways

The Effects of the AI Revolution

The Question of AI Accuracy

How AI is Shortening Drug Timelines

PharmTech Weekly Roundup - February 27, 2026

Is the Era of Animal Testing Ending for Rare Diseases

The New Reality of Supply Chains

PharmTech Weekly Roundup - February 20, 2026

The Struggle of Clinical Trials for Rare Diseases

The Truth About Competition in Rare Disease Drugs

Beyond Hardware: The Power of Chemical Software

PharmTech Weekly Roundup - February 13, 2026

The Mindset of a Successful CEO

Why Small Molecules Aren't Small Anymore

PharmTech Weekly Roundup - February 6, 2026

Why STEM Programs Matter–Closing the Leadership Gap

Developing Smarter Therapies for Cancer Patients

Why Early STEM Engagement is Crucial for Human Health

Modernizing USP Standards for a Greener Future

Stop Relying on Heroics: Plan for Predictable Risk

The Real Risk: It's Not the Shutdown, It's the Recovery